Australia, Nov. 18 -- Regeneron Pharmaceuticals Inc., owns the trademark (2583252) for 'VELOCIVAX' till Sept. 3, 2035.
Status: registered:
Registered/protected
Class: 42 [Pharmaceutical research services, namely, nucleic acid molecule development and nucleic acid molecule delivery development and production; genetic engineering services utilizing a collection of genetic technologies for the production and delivery of immune modulators; scientific, laboratory and medical research in the field of genetic engineering technologies; scientific laboratories performing nucleic acid molecule development and nucleic acid molecule delivery development; scientific research and development, namely, development of nucleic acid molecule and nucleic acid molecule delivery for others]
Type of Mark: Word
Date of Acceptance: Sept. 10
Registration Advertised: Nov. 17
For further details contact PHILLIPS ORMONDE FITZPATRICK.
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2583252.
Disclaimer: Curated by HT Syndication.
